When is a point of view a conflict of interest?

Lenzer J. BMJ. 2016;355.

The ugly (and true) history of the FDA’s rejection of advisors who raised concerns about drug and device safety while relying on advisors with ties to industry: Conversely, the agency was unable to name a single advisor recused for their enthusiastic embrace of a drug or device.